Scarica l'app Stockscreener
1.85
4.15%
-0.08
Dopo l'orario di chiusura:
1.86
0.01
+0.54%
Precedente Chiudi:
$1.93
Aprire:
$1.92
Volume 24 ore:
392.16K
Relative Volume:
0.31
Capitalizzazione di mercato:
$49.18M
Reddito:
$155.00K
Utile/perdita netta:
$-30.01M
Rapporto P/E:
-1.1078
EPS:
-1.67
Flusso di cassa netto:
$-11.98M
1 W Prestazione:
-6.57%
1M Prestazione:
-7.04%
6M Prestazione:
-74.69%
1 anno Prestazione:
-64.49%
Intervallo 1D:
$1.85
$2.00
Intervallo di 1 settimana:
$1.7847
$2.00
Portata 52W:
$1.71
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Nome
Inmune Bio Inc
Settore
Industria
Telefono
(858) 964-3720
Indirizzo
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Confronta INMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.85 | 49.71M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-01 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-21 | Iniziato | Alliance Global Partners | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-01 | Iniziato | Robert W. Baird | Outperform |
| 2022-05-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-21 | Iniziato | B. Riley Securities | Buy |
| 2021-01-22 | Reiterato | Maxim Group | Buy |
| 2020-09-01 | Iniziato | BTIG Research | Buy |
| 2020-07-15 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Inmune Bio Inc Borsa (INMB) Ultime notizie
Is it time to cut losses on INmune Bio Inc.July 2025 Intraday Action & Precise Entry and Exit Recommendations - newser.com
Chart overlay techniques for tracking INmune Bio Inc.Dip Buying & Free Weekly Watchlist of Top Performers - newser.com
Will INmune Bio Inc. stock outperform tech sector in 2025Portfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com
How INmune Bio Inc. stock benefits from global expansionWeekly Trade Analysis & Fast Gaining Stock Reports - newser.com
INmune Bio CEO to Speak at Maxim Growth Summit - TipRanks
Inmune Bio Inc Announces Participation in Dermatologic Panel - TradingView
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025 - The Manila Times
Oct 22 CEO Panel: INmune Bio's CORDStrom for RDEB — David Moss at Maxim Growth Summit in NYC - Stock Titan
Can volume confirm reversal in INmune Bio Inc.July 2025 Closing Moves & Weekly Market Pulse Alerts - newser.com
Sector ETF performance correlation with INmune Bio Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
INmune Bio Inc Stock Analysis and ForecastCandlestick Trading Patterns & Free Rapid Profit Acceleration - earlytimes.in
INmune Bio Inc. stock trend outlook and recovery pathMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
How to track smart money flows in INmune Bio Inc.July 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
What does recent volatility data suggest for INmune Bio Inc.Portfolio Performance Summary & AI Driven Price Forecasts - newser.com
INmune Bio (NASDAQ:INMB) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
INmune Bio, Inc. (NASDAQ:INMB) Receives Average Rating of "Hold" from Analysts - MarketBeat
Using RSI to spot recovery in INmune Bio Inc.Market Weekly Review & Weekly High Conviction Ideas - newser.com
Analyzing INmune Bio Inc. with risk reward ratio chartsGDP Growth & Safe Capital Growth Tips - newser.com
Predicting INmune Bio Inc. trend using moving averagesJuly 2025 Action & Target Return Focused Picks - newser.com
Inmune Bio Submits Manuscript on Alzheimer’s Trial - TipRanks
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results - Investing.com
Inmune Bio announces submission of phase 2 mindful trial results in Alzheimer's - MarketScreener
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results By Investing.com - Investing.com Australia
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal - Yahoo Finance
Zero ARIA Side Effects: INmune Bio's Alzheimer's Drug Shows Safety Edge Over Amyloid Therapies - Stock Titan
What analysts say about INmune Bio Inc stockTechnical Breakout Signals & Free Daily Stock Hotspot Analysis - Early Times
AI Stocks: Whats the profit margin of INmune Bio IncJuly 2025 Retail & Community Consensus Stock Picks - خودرو بانک
Analysis Recap: Is INmune Bio Inc. forming a double bottomEarnings Summary Report & Fast Moving Market Watchlists - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Update - MarketBeat
Aug Macro: Whats the profit margin of INmune Bio IncEarnings Risk Summary & High Accuracy Trade Alerts - khodrobank.com
How does Battalion Oil Corporation compare to its peersWeekly Investment Report & AI Enhanced Trading Signals - khodrobank.com
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Risk Analysis: Can INmune Bio Inc stock outperform in a bear marketJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - خودرو بانک
Will INmune Bio Inc outperform the market in YEAR2025 Biggest Moves & Weekly Stock Performance Updates - خودرو بانک
Block Trades: What are INmune Bio Incs earnings expectationsQuarterly Growth Report & Safe Entry Zone Identification - khodrobank.com
Has INmune Bio Inc. formed a bullish divergenceJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Retail Surge: Is INmune Bio Inc a stock for growth or value investorsQuarterly Investment Review & AI Driven Stock Reports - خودرو بانک
Aug Macro: Is INmune Bio Inc. impacted by rising rates2025 Geopolitical Influence & AI Based Trade Execution Alerts - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Receives $18.40 Consensus PT from Analysts - Defense World
Inmune Bio Inc Azioni (INMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):